1. Home
  2. VYGR vs SI Comparison

VYGR vs SI Comparison

Compare VYGR & SI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.85

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

SI

Shoulder Innovations Inc.

HOLD

Current Price

$12.97

Market Cap

269.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
SI
Founded
2013
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
227.2M
269.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
SI
Price
$3.85
$12.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$16.50
$20.80
AVG Volume (30 Days)
488.9K
59.7K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
$34.04
$39.59
Revenue Next Year
$7.92
$31.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$10.92
52 Week High
$5.55
$17.23

Technical Indicators

Market Signals
Indicator
VYGR
SI
Relative Strength Index (RSI) 47.72 43.36
Support Level $3.72 $11.65
Resistance Level $4.31 $13.63
Average True Range (ATR) 0.16 0.88
MACD -0.02 -0.13
Stochastic Oscillator 31.91 29.57

Price Performance

Historical Comparison
VYGR
SI

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About SI Shoulder Innovations Inc.

Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.

Share on Social Networks: